THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 113 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $929,865 | -26.2% | 107,748 | -11.4% | 0.01% | -40.0% |
| Q2 2023 | $1,259,243 | +106706.0% | 121,666 | +12.0% | 0.02% | -16.7% |
| Q1 2023 | $1,179 | +12.5% | 108,635 | +16.3% | 0.02% | -14.3% |
| Q4 2022 | $1,048 | -99.9% | 93,434 | -9.5% | 0.02% | -16.0% |
| Q2 2022 | $936,000 | +206.9% | 103,280 | +223.6% | 0.02% | +257.1% |
| Q1 2022 | $305,000 | -84.1% | 31,916 | -81.6% | 0.01% | -78.1% |
| Q4 2021 | $1,916,000 | +400.3% | 173,414 | +235.4% | 0.03% | +433.3% |
| Q3 2021 | $383,000 | +5.8% | 51,709 | +86.0% | 0.01% | -45.5% |
| Q2 2015 | $362,000 | – | 27,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |